Work

A Novel, Potent, and Selective 5-HT7Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)

Year: 2000

Type: article

Source: Journal of Medicinal Chemistry

DOI: 10.1021/jm991151j

Authors: Peter J. Lovell, Steven M. Bromidge, Steven Dabbs, D. Malcolm Duckworth, Ian T. Forbes, Andrew J. Jennings, Frank D. King, Derek N. Middlemiss, Shirley K. Rahman, Damian V. Saunders, Lissa L. Collin, Jim J. Hagan, Graham J. Riley, David R. Thomas

Institution: GlaxoSmithKline (United Kingdom)

Language: English

Topic: Receptor Mechanisms and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2095054997

FWCI: 4.678

Cites: 10

Cited by: 257

Related to: 10